Peak Bio, Inc.
PKBODelisted Mar 3, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001834645
Peak Bio, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Dec 4, 2024; 9 institutions reported holding it in 13F filings for Q4 2022, worth $2.53M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Peak Bio, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Peak Bio, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Ikbc-Sbi Bio Fund 1 | Director | 0 | Dec 4, 2024 | 0 |
| Sbi Cross-Border Advantage Fund | Director | 0 | Dec 4, 2024 | 0 |
| Sbi Healthcare Fund I | Director | 0 | Dec 4, 2024 | 0 |
| Sbi Investment Korea Co., Ltd. | Director | 0 | Dec 4, 2024 | 0 |
| Patel Sandip I | Director | 0Indirect | Nov 18, 2024 | 0 |
| Neal James R | Director | 0 | Nov 18, 2024 | 0 |
| Huh Hoyoung | Director, 10% Owner | 0Indirect | Nov 18, 2024 | 0 |
| 2014 Kif-Sbi It Investment Fund | 10% Owner | 0 | Mar 5, 2024 | 0 |
| LaMond Stephen J | See Remarks | 19,850 | Sep 28, 2023 | 0 |
| Rosenberg David I. | Director | 1,514,700Indirect | Nov 3, 2022 | 0 |
| Mitra Satyajit Kumar | See Remarks | – | Nov 3, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 28, 2023 (view filing) | Sep 26-27 | 2 days | LaMond Stephen JSee Remarks | PPurchase | +5.60K | – | – | +39.3%19.9K after | 2 lots |
| Sep 28, 2023 (view filing) | Sep 15-18 | 13 days | LaMond Stephen JSee Remarks | PPurchase | +14.3K | – | – | New position14.3K after | Amended2 lots |
| Sep 25, 2023 (view filing) | Sep 21 | 4 days | Huh HoyoungDirector, 10% Owner | PPurchase | +45.0K | – | – | +0.5%8.38M after | |
| Sep 21, 2023 (view filing) | Sep 19-20 | 2 days | Huh HoyoungDirector, 10% Owner | PPurchase | +80.0K | – | – | +1.0%8.34M after | 2 lots |
| Sep 19, 2023 (view filing) | Sep 15 | 4 days | Huh HoyoungDirector, 10% Owner | PPurchase | +25.0K | – | – | +0.3%8.26M after | |
| Sep 15, 2023 (view filing) | Sep 13-14 | 2 days | Huh HoyoungDirector, 10% Owner | PPurchase | +50.0K | – | – | +0.6%8.23M after | 2 lots |
| Sep 13, 2023 (view filing) | Sep 11-12 | 2 days | Huh HoyoungDirector, 10% Owner | PPurchase | +47.0K | – | – | +0.6%8.18M after | 2 lots |
| Sep 12, 2023 (view filing) | Aug 29-31 | 14 days | Huh HoyoungDirector, 10% Owner | PPurchase | 0 | – | $0 | 0.0%8.14M after | Amended7 lots |